Stay updated on NANT Melanoma Vaccine Combo Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NANT Melanoma Vaccine Combo Immunotherapy Clinical Trial page.

Latest updates to the NANT Melanoma Vaccine Combo Immunotherapy Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the NANT melanoma combination-immunotherapy study is now displayed, with its eligibility criteria, treatment plan, and outcome measures. The record states that the trial was withdrawn and not initiated.SummaryDifference74%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide notice announces NIH website updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content. This indicates that access to the record is blocked rather than a content update.SummaryDifference23%

Stay in the know with updates to NANT Melanoma Vaccine Combo Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NANT Melanoma Vaccine Combo Immunotherapy Clinical Trial page.